This study investigates the extent to which phonetic voicing is maintained in word-final clusters composed of an underlying voiced stop followed by nonsyllabic/l/ or /r/ in Majorcan Catalan. Electropalatographic and acoustic data for five speakers of this Catalan dialect reveal that, in agreement with the non-syllabic status of the liquid, voicing for /l/ is only available if occurring during the preceding stop. The rhotic is always phonetically voiceless. Speakers differ regarding the extent to which they keep the underlying stop voicing distinction and the production strategies they use for that purpose. This distinction is highly robust and distributed over the entire syllable in nasal-stop-/l/ clusters for some speakers, but much less clear or absent for those speakers who devoice /l/ as a general rule. Underlying stop voicing is cued primarily by stop closure duration and vocal fold vibration, or else by closure duration rather than by voicing. It may be concluded that the word-final devoicing process operating in Catalan does not apply to Majorcan Catalan tautosyllabic stop clusters with a liquid, and that phonetic voicing may affect just the stop or both the stop and the liquid. The implications of these findings for sound change are discussed.

This content is only available via PDF.
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.